Development of pneumonia in desert bighorn sheep after exposure to a flock of exotic wild and domestic sheep.
From 1986 to 1989, 5 desert bighorn sheep (3 Ovis canadensis mexicana and 2 O c nelsoni), ranging in age from 2 to 3 years, were exposed to a flock of exotic wild and domestic sheep to potentially achieve naturally acquired pneumonia. Pasteurella multocida was isolated from nasal samples from 4 of 6 sheep randomly sampled from the flock. Bighorn sheep were exposed individually and each exposure period was a trial. Treatment before and after exposure varied and included combinations of alpha interferon, antibiotics, anti-inflammatory drugs, and vaccines. Treatments were chosen on the basis of recommendations of others for treating pneumonia in desert bighorn sheep as well as our own experience in sheep and cattle. Regardless of treatment used, bighorn sheep in trials 1 to 4 developed signs of pneumonia within 10 to 14 days of exposure. Bighorn sheep in trials 1 to 3 died within 11 to 17 days of initial exposure. In trial 4, the bighorn sheep was isolated from the carrier sheep for treatment of pneumonia on day 14 and died on day 30. Pasteurella multocida was isolated from lung tissue in 3 of the 4 bighorn sheep. On the basis of results of trials 1 to 4, a more in depth clinical study was conducted in trial 5. Nasal and blood specimens were collected prior to and during trial 5 for bacteriologic culturing and serologic testing for bovine viral diarrhea virus, infectious bovine rhinotracheitis, parainfluenza-3 virus, and respiratory syncytial virus.(ABSTRACT TRUNCATED AT 250 WORDS)
Callan
R J
RJ
Department of Animal Dairy and Veterinary Sciences, Utah State University, Logan 84322.
Bunch
T D
TD
Workman
G W
GW
Mock
R E
RE
D000818:Animals; D000829:Animals, Domestic; D000835:Animals, Wild; D001428:Bacterial Vaccines; D002353:Carrier State / Q000662:veterinary*; D004359:Drug Therapy, Combination; D005260:Female; D007370:Interferon Type I / Q000627:therapeutic use; D008297:Male; D010325:Pasteurella / Q000276:immunology; D012766:Pasteurellosis, Pneumonic / Q000188:drug therapy / Q000517:prevention & control / Q000635:transmission*; D012756:Sheep; D012757:Sheep Diseases / Q000188:drug therapy / Q000517:prevention & control / Q000635:transmission*
D001428:Bacterial Vaccines; D007370:Interferon Type I